AlphaGenome 使用人类和小鼠基因组的公共数据库进行训练,从而学会 DNA 变化与生物过程之间的模式。将这些预测应用于数十亿种可能的变体,产生了一个 Google 称大约为 1 petabyte(拍字节)大小的庞大数据集。
公司表示,从今天起,它将通过网站向研究人员提供 Atlas 供非商业使用,并将在“近期”通过 Google Cloud 提供商业使用。
Atlas 是谷歌一系列利用人工智能解决科学和医学核心问题的最新尝试之一,此时 DeepMind 联合创始人 Demis Hassabis 从管理 AI 实验室的工作中退居二线,专注于科学研究:/podcast/979370/google-deepmind-ai-race-lose-jeff-dean-demis-hassabis,包括领导药物研发衍生公司 Isomorphic Labs。该公司在这一领域最知名的工作是 AlphaFold,一种蛋白质结构预测模型,使 Demis Hassabis 和 John Jumper 赢得了 2024 年诺贝尔化学奖:https://www.nobelprize.org/prizes/chemistry/2024/popular-information/。该公司还开发了用于天气预测的 AI 工具:/tech/988921/weather-forecast-ai-model-google-satellite-update,优化计算和数学中寻找新解决方案的能力:/news/666377/googles-says-its-new-ai-agent-can-find-new-solutions-in-computing-and-math,并通过代理式“合作科学家”帮助研究人员:https://deepmind.google/blog/co-scientist-a-multi-agent-ai-partner-to-accelerate-research/。
Google DeepMind has unveiled an AI tool that its scientists claim could help unravel the mysteries of the human genome and transform our understanding of biology, accelerating scientific research and ultimately paving the way for new treatments for diseases.
The platform, called AlphaGenome Atlas, contains a “predictive map of every possible DNA letter change in the human genome,” the researchers said in a blog post:https://deepmind.google/blog/alphagenome-atlas-a-predictive-map-of-every-possible-dna-letter-change-in-the-human-genome published on Tuesday.
DNA is written in an alphabet of four chemical “letters” — usually shortened to A, C, G, and T — and the human genome contains roughly three billion letter pairs. Those letters contain the instructions that make life work, such as how, when, and where genes are switched on and off, and to what degree. Changes to individual letters can be harmless, contribute to ordinary differences between people, or play a role in disease – a major challenge is figuring out which changes matter and how. It is a tough task as there are roughly nine billion potential single-letter substitutions.
Atlas contains predictions for how each of these nine billion variants could affect the body at a molecular level, such as changing how much of a particular protein is produced. The researchers call it “the most comprehensive catalogue of how genetic mutations affect molecular biology.” Google says scientists can explore these predictions through a web portal, as a skill in its agentic development platform Antigravity, and through its AlphaGenome interface.
To help researchers sift through the billions of possibilities and focus on the mutations that warrant closer attention, Google is also releasing what it calls a Variant Impact Score (AVI), that draws on the company’s other models for predicting the effects of DNA changes. “Now, researchers can rapidly rank variants and interpret their molecular effects at the same time,” the company’s blog said.
The project builds on AlphaGenome:https://deepmind.google/blog/alphagenome-ai-for-better-understanding-the-genome/, an AI model DeepMind unveiled last year to help scientists identify the genetic drivers of disease, as well as AlphaMissense:https://deepmind.google/blog/a-catalogue-of-genetic-mutations-to-help-pinpoint-the-cause-of-diseases/, an earlier tool focused on predicting which small mutations might alter proteins. Atlas goes much further, extending predictions across the genome, including the vast majority of stretches that do not directly code for proteins, but can instead control how genes behave.
In a press briefing, Ziga Avsec, DeepMind’s genomics lead, acknowledged that the underlying model — AlphaGenome — had already been released, but said turning its capabilities into a genome-wide catalog took time. “Basically it took us some time to really precompute and also analyze this many variants because the space is so big,” he said.
AlphaGenome was trained using public databases of human and mouse genomes, allowing it to learn patterns between DNA changes and biological processes. Applying those predictions to billions of possible variants produced a massive dataset that Google says is roughly 1 petabyte in size.
The company says it is making Atlas available to researchers for noncommercial use through its website starting today, and for commercial use on Google Cloud “soon.”
Atlas is the latest in a string of efforts from Google to use AI to tackle core problems in science and medicine, coming at a time when DeepMind cofounder Demis Hassabis steps back from running the AI lab to focus on scientific research:/podcast/979370/google-deepmind-ai-race-lose-jeff-dean-demis-hassabis, including leading drug-discovery spinoff Isomorphic Labs. The company’s best-known work in this area is AlphaFold, the protein-structure prediction model that won Demis Hassabis and John Jumper the 2024 Nobel Prize in Chemistry:https://www.nobelprize.org/prizes/chemistry/2024/popular-information/. The company has also developed AI tools for predicting the weather:/tech/988921/weather-forecast-ai-model-google-satellite-update, optimizing finding new solutions in computing and mathematics,:/news/666377/googles-says-its-new-ai-agent-can-find-new-solutions-in-computing-and-math and assisting researchers through an agentic “co-scientist:https://deepmind.google/blog/co-scientist-a-multi-agent-ai-partner-to-accelerate-research/.”